Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2009 2
2010 5
2011 4
2012 5
2013 7
2014 11
2015 9
2016 19
2017 9
2018 11
2019 10
2020 8
2021 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 27280803

101 results

Results by year

Filters applied: . Clear all
Page 1
Dengue Vaccine: Considerations before Rollout in Colombia.
Villabona-Arenas CJ, Ocazionez Jimenez RE, Jimenez Silva CL. Villabona-Arenas CJ, et al. PLoS Negl Trop Dis. 2016 Jun 9;10(6):e0004653. doi: 10.1371/journal.pntd.0004653. eCollection 2016 Jun. PLoS Negl Trop Dis. 2016. PMID: 27280803 Free PMC article. No abstract available.
Dengue fever climbs the social ladder.
[No authors listed] [No authors listed] Nature. 2007 Aug 16;448(7155):734-5. doi: 10.1038/448734a. Nature. 2007. PMID: 17700664 No abstract available.
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Cortés M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M; CYD-TDV Dengue Vaccine Working Group. Hadinegoro SR, et al. N Engl J Med. 2015 Sep 24;373(13):1195-206. doi: 10.1056/NEJMoa1506223. Epub 2015 Jul 27. N Engl J Med. 2015. PMID: 26214039 Free article. Clinical Trial.
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Biswal S, Borja-Tabora C, Martinez Vargas L, Velásquez H, Theresa Alera M, Sierra V, Johana Rodriguez-Arenales E, Yu D, Wickramasinghe VP, Duarte Moreira E Jr, Fernando AD, Gunasekera D, Kosalaraksa P, Espinoza F, López-Medina E, Bravo L, Tuboi S, Hutagalung Y, Garbes P, Escudero I, Rauscher M, Bizjajeva S, LeFevre I, Borkowski A, Saez-Llorens X, Wallace D; TIDES study group. Biswal S, et al. Lancet. 2020 May 2;395(10234):1423-1433. doi: 10.1016/S0140-6736(20)30414-1. Epub 2020 Mar 17. Lancet. 2020. PMID: 32197105 Clinical Trial.
Prospects for a dengue virus vaccine.
Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Whitehead SS, et al. Nat Rev Microbiol. 2007 Jul;5(7):518-28. doi: 10.1038/nrmicro1690. Nat Rev Microbiol. 2007. PMID: 17558424 Review.
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
Biswal S, Reynales H, Saez-Llorens X, Lopez P, Borja-Tabora C, Kosalaraksa P, Sirivichayakul C, Watanaveeradej V, Rivera L, Espinoza F, Fernando L, Dietze R, Luz K, Venâncio da Cunha R, Jimeno J, López-Medina E, Borkowski A, Brose M, Rauscher M, LeFevre I, Bizjajeva S, Bravo L, Wallace D; TIDES Study Group. Biswal S, et al. N Engl J Med. 2019 Nov 21;381(21):2009-2019. doi: 10.1056/NEJMoa1903869. Epub 2019 Nov 6. N Engl J Med. 2019. PMID: 31693803 Clinical Trial.
101 results